Head and Neck Cancer Trial, Recruiting NCT06308328 Sponsor: Nanfang Hospital, Southern Medical University Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06308328
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to provide written consent to participate.
  • People who are 18 years of age or older.
  • People who have been diagnosed with nasopharyngeal carcinoma (a type of cancer in the back of the nose and throat) confirmed by tissue testing, and who are currently receiving intensive radiation therapy or a combination of chemotherapy and radiation therapy.
  • People who have complete and ongoing records of mouth and throat mucositis (soreness and inflammation) grading, as well as their own reported pain when swallowing.

Who may not be able to join:

  • People who have poor oral hygiene, untreated dental or gum disease, or metal dental restorations (such as certain fillings or crowns).
  • People who have unstable heart conditions currently requiring treatment, or diabetes that is not well controlled.
  • People whose body weight is considered too low relative to their height, specifically a Body Mass Index (BMI) below 18.5 (confirm with trial site).
  • People who the trial researchers determine are otherwise not suitable to participate, based on their assessment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jian Guan, Ph.D., Nanfang Hospital, Southern Medical University

Phone: +86-13632102247

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanfang Hospital, Southern Medical University
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
30 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The AUC of the predictive model

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov